John P. Saharek
Overview
John P. Saharek received an average of $928K in total compensation, including $291K in salary, at Imprimis Pharmaceuticals from 2015 to 2022.
2022Imprimis PharmaceuticalsChief Commercial Officer and President, ImprimisRx
2021Imprimis PharmaceuticalsPresident, ImprimisRx
2020Imprimis PharmaceuticalsPresident, ImprimisRx
2019Imprimis PharmaceuticalsPresident, ImprimisRx
2018Imprimis PharmaceuticalsChief Commercial Officer
2017Imprimis PharmaceuticalsChief Commercial Officer
2016Imprimis PharmaceuticalsChief Commercial Officer
2015Imprimis PharmaceuticalsChief Commercial Officer
Source: SEC filings on April 28, 2023, April 26, 2022, April 23, 2021, April 24, 2020, April 25, 2019, April 30, 2018, and April 27, 2017.
Related executives
We found six more executives who work or worked at Imprimis Pharmaceuticals.
Mark Baum
Imprimis Pharmaceuticals
Chief Executive Officer
Andrew Boll
Imprimis Pharmaceuticals
Chief Financial Officer
Balbir Brar
Imprimis Pharmaceuticals
Former President
Joachim Schupp
Imprimis Pharmaceuticals
Chief Medical Officer
Juliet Singh
Imprimis Pharmaceuticals
Chief Executive Officer
John Lomoro
Imprimis Pharmaceuticals
Chief Financial Officer
News
Imprimis Pharmaceuticals CEO Mark Baum's 2022 pay falls 84% to $1.2M
April 28, 2023
Imprimis Pharmaceuticals CEO Mark Baum's 2021 pay jumps 195% to $7.3M
April 26, 2022
Imprimis Pharmaceuticals CEO Mark Baum's 2020 pay jumps 80% to $2.5M
April 23, 2021
Imprimis Pharmaceuticals CEO Mark Baum's 2019 pay jumps 30% to $1.4M
April 24, 2020
Imprimis Pharmaceuticals CEO Mark Baum's 2018 pay rises 16% to $1.1M
April 25, 2019